Home > PS Ratio > JAGSONPAL PHARMACEUTICALS

JAGSONPAL PHARMACEUTICALS
PS (Price/Sales) Ratio

The Current P/S Ratio of JAGSONPAL PHARMACEUTICALS is 6.38.

Share Price ₹271.2Aug 01,2025
Market Cap ₹1,805.9 Cr
Sales-TTM₹282.9 CrTTM-Standalone Results
Price/Sales6.38xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for JAGSONPAL PHARMACEUTICALS
Please provide your vote to see the results
JAGSONPAL PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of JAGSONPAL PHARMACEUTICALS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of JAGSONPAL PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹1,805.9 Cr] as on Aug 01,2025

(/) Sales [ ₹282.9 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 6.38x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for JAGSONPAL PHARMACEUTICALS , the investors are currently willing to pay '6.38 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of JAGSONPAL PHARMACEUTICALS !

The chart below summarizes the trend in P/S Ratio of JAGSONPAL PHARMACEUTICALS over the last five years.

Historical PS (Price/Sales) ratio chart of JAGSONPAL PHARMACEUTICALS


PS Ratio Performance Analysis for JAGSONPAL PHARMACEUTICALS

- JAGSONPAL PHARMACEUTICALS 's latest p/e ratio is 6.38x.

- JAGSONPAL PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.39x.

- JAGSONPAL PHARMACEUTICALS 's operated at median p/e ratio of 3.21x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, JAGSONPAL PHARMACEUTICALS 's p/e ratio peaked in Mar2022 at 3.78x.

- JAGSONPAL PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 0.29x.


How does JAGSONPAL PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
JAGSONPAL PHARMACEUTICALS 282.96.381,805.9
SUN PHARMACEUTICAL INDUSTRIES LTD53,777.17.27390,864.0
DIVIS LABORATORIES LTD9,360.018.04168,811.0
CIPLA LTD27,811.24.36121,260.0
TORRENT PHARMACEUTICALS LTD11,835.010.51124,352.0
DR REDDYS LABORATORIES LTD33,519.93.04101,786.0
MANKIND PHARMA LTD12,956.28.16105,753.0
ZYDUS LIFESCIENCES LTD23,241.54.1195,486.6
LUPIN LTD22,707.93.7585,203.9
AUROBINDO PHARMA LTD31,723.71.9862,709.1
ABBOTT INDIA LTD6,409.211.1771,559.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs JAGSONPAL PHARMACEUTICALS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 1.98x
Max industry PS 18.04x
Median industry PS 6.38x
Average industry PS 7.16x



You may also like the below Video Courses